Rang	Name	Position
1	Mr. Thomas Lingelbach	President, CEO & Director
2	Mr. Peter Buhler	Chief Financial Officer
3	Dr. Juan-Carlos Jaramillo M.D.	Chief Medical Officer
4	Ms. Dipal Patel	Chief Commercial Officer
5	Mr. Vincent Dequenne	Chief Operating Officer
6	Dr. Hanneke Schuitemaker Ph.D.	Chief Scientific Officer
7	Mr. Joshua Drumm Ph.D.	Vice President of Investor Relations
8	Ms. Laetitia Bachelot-Fontaine	VP of Global Communications & European Investor Relations
9	Ms. Petra Pesendorfer	Chief People Officer
10	Katrin Dubischar	VP & Program Director of Chikungunya Vaccine

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Frazier Life Sciences Management, L.P.	2,42%	13,15 Mio. USD
2	Vivo Capital, LLC	0,80%	4,38 Mio. USD
3	General American Investors Co Inc	0,37%	2,03 Mio. USD
4	Millennium Management LLC	0,14%	0,78 Mio. USD
5	Wells Fargo & Co	0,08%	0,44 Mio. USD
6	Morgan Stanley - Brokerage Accounts	0,06%	0,32 Mio. USD
7	Ironwood Investment Management LLC	0,05%	0,26 Mio. USD
8	Citadel Advisors Llc	0,02%	0,12 Mio. USD
9	XTX Topco Ltd	0,02%	0,09 Mio. USD
10	VSM Wealth Advisory, LLC	0,01%	0,06 Mio. USD
11	UBS Group AG	0,00%	0,03 Mio. USD
12	GAMMA Investing LLC	0,00%	0,02 Mio. USD
13	Rhumbline Advisers	0,00%	0,01 Mio. USD
14	Steigerwald, Gordon & Koch Inc.	0,00%	0,01 Mio. USD
15	BNP Paribas Arbitrage, SA	0,00%	0,00 Mio. USD
16	Larson Financial Group, LLC	0,00%	0,00 Mio. USD
17	Advisor Group Holdings, Inc.	0,00%	0,00 Mio. USD
18	Caitong International Asset Management Co., Limited.	0,00%	0,00 Mio. USD
19	Activest Wealth Management	0,00%	0,00 Mio. USD
20	EverSource Wealth Advisors, LLC	0,00%	0,00 Mio. USD